Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01723020
Title A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | FRA

Facility Status City State Zip Country Details
Research Site Santa Monica California 90403 United States Details
Research Site Norwalk Connecticut 06856 United States Details
Research Site Boston Massachusetts 02115 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site Hackensack New Jersey 07601 United States Details
Research Site New Brunswick New Jersey 08901 United States Details
Research Site New York New York 10021 United States Details
Greenville Hospital System Greenville South Carolina 29605 United States Details
Research Site Greenville South Carolina 29605 United States Details
Research Site Lyon CEDEX 08 69373 France Details
Research Site Villejuif 94805 France Details
Research Site Amsterdam 1066 CX Netherlands Details
Research Site Rotterdam 3015 CE Netherlands Details
Research Site Utrecht 3584 CX Netherlands Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field